Is Kenvue Stock a Buy After Earnings?
If you've ever been to a convenience store, odds are that you've encountered products sold by Kenvue (NYSE: KVUE). If that name doesn't sound familiar, it might be because until recently Kenvue's products were part of a larger conglomerate, Johnson & Johnson.
Earlier this year, Johnson & Johnson spun off its consumer health business, home to recognizable brands including Aveeno, Listerine, Neutrogena, Tylenol, and Zyrtec.
Kenvue just held its first earnings report as a stand-alone public company, and beat Wall Street expectations on both the top and bottom lines. Although its history as an independent entity is limited, there are some reasons why investors may want to scoop some shares up in the consumer giant.
Source Fool.com
